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In December 2012, the Joint Research Centre 
(JRC), which is the European Commission’s 
(EC) in-house science service, was assigned 
by the Directorate-General for Health and 
Consumers (now the Directorate-General 
for Health and Food Safety–DG SANTE) 
with the task of coordinating the European 
Commission Initiative on Breast Cancer 
(ECIBC). Further details can be retrieved in 
the following sources:
• European Commission Initiative on
 Breast Cancer: Concept document.
• JRC webpage: European Commission
 Initiative on Breast Cancer–ECIBC.
The JRC set up a dedicated team for coordi-
nating the ECIBC; the Healthcare Quality 
team (HQ). ECIBC main tasks as defined 
by the DG SANTE document are:
1. To develop a new version of the European 
guidelines for breast cancer screening and 
diagnosis based on new knowledge and 
evidence;
2. To develop a voluntary European quality 
assurance (QA) scheme for breast can-
cer services based on the EU legislative 
framework on accreditation, as defined 
in the Regulation of the European Parlia-
ment and by the Council of Europe set-
ting out the requirements for accredita-
tion and market surveillance.
With regard to guidelines covering stages 
other than screening and diagnosis, a plat-
form for breast cancer guidelines is envis-
aged to host existing evidence-based, high-
quality guidelines.
Other tasks, such as the development of the 
ECIBC web hub and the definition of a con-
cept for training of professionals in breast 
cancer screening, were included. Moreover, 
tasks functional to the creation of the neces-
sary knowledge platform were also assigned 
and new tasks will be added, as needed.
In order to develop the ECIBC project in 
a coordinated, consensus-based and sus-
tainable way, the JRC set up a series of tar-
geted meetings with a wide range of stake-
holders involved in similar initiatives (past 
and current), including medical oncology 
professionals, accreditation bodies, patient 
organisations, methodologists, experts and 
concerned national authorities. The JRC 
also participated in external meetings and 
conferences in order to acquire the basic 
knowledge for starting the activities of the 
ECIBC and to inform stakeholders about 
the ECIBC’s aim and tasks.
The present report is a summary of the 2015 
meetings aimed at helping the preparation 
of the above mentioned tasks. The meet-
ings organised between 2011 and 2014 are 
described in the JRC reports European Com-
mission Initiative on Breast Cancer–ECIBC: 
organisation of project guiding and support meet-
ings–Meetings 2011-2013 and, respectively, 
Euro pean Commission Initiative on Breast Can-
cer–ECIBC: organisation of project guiding 
and support meetings–Meetings 2014.
Abstract
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The ECIBC is coordinated by the JRC’s 
Institute for Health and Consumer Protec-
tion (JRC-IHCP). This initiative responds 
to the Council Conclusions on reducing the 
burden of cancer 1 and it aims to mitigate the 
risks associated with inadequate quality of 
prevention and care. In this context, the 
tasks of the initiative can be summarised as 
(i) establishing a minimum set of evidence-
based quality requirements for breast cancer 
care across Europe assessed and monitored 
via the accreditation legal framework (a vol-
untary European quality assurance scheme 
for breast cancer services) while (ii) develop-
ing the evidence underpinning the scheme, 
namely the new European guidelines for breast 
cancer screening and diagnosis (hereinafter 
mentioned as new European Guidelines) and 
a platform for existing guidelines for other 
stages of care. Its concept foresees that all 
aspects of breast cancer prevention and care, 
screening, diagnosis, treatment, survivor-
ship–support–palliative care and manage-
ment of recurrence (follow-up) are covered. 
1. Council of the European Union. Council Conclusions on reduc-
ing the burden of cancer. 2876th Employment, Social Policy, Health 
and Consumer Affairs Council Meeting. Luxembourg, 10 June 
2008.
In addition, the initiative will: (iii) develop a 
concept for training health professionals in-
volved in digital mammography screening 
programmes; and (iv) develop a concept for 
the ECIBC web hub which should act as a 
host for all its deliverables in order to make 
them easily accessible to target users.
These four tasks are strongly interlinked and 
their accomplishment will rely on inputs 
from relevant European and international 
stakeholders, experts and participating 
countries (Member States–MSs, plus Swit-
zerland, Iceland, Montenegro, Norway, Ser-
bia, Turkey). Therefore, a series of meetings 
targeting the widest possible audience of in-
terested parties began in 2012. As these meet-
ings were an important source of informa-
tion and a platform for consensus for future 
stages of the project, the JRC will continue 
to invest ECIBC resources to disseminate 
the information related to the project and to 
identify and meet with stakeholders.
1. Introduction
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This report includes a description of the 
context and outcomes of the meetings held 
in 2015, the news about the ECIBC and the 
relevant stakeholders the JRC met during 
2015. JRC staff involved in the meetings in-
cluded the IHCP Director, the Head of Unit 
for Public Health Policy Support (PHPS) 
and PHPS staff, in particular the Healthcare 
Quality (HQ) team. Only meetings and 
events which target the ECIBC are included 
in the present report.
Meetings involving the JRC and the main 
customer, DG SANTE, the Expert Group 
on Cancer Control or other concerned DGs 
and EU bodies, like Directorate-General 
for Research and Innovation (DG RTD), 
Directorate-General for Enterprise and In-
dustry (DG GROW) are cited but not fully 
described as they do not fall under the scope 
of this report. Also for the big events organ-
ised by JRC in the framework of the ECIBC 
separate reports are prepared.
2. Scope
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The methods used for identifying relevant 
stakeholders have already been described in 
the report European Commission Initiative on 
Breast Cancer–ECIBC: organisation of project 
guiding and support meetings–Meetings 2011-
2013.
The same structure of the interactions with 
the stakeholders as in the previous meetings 
reports was kept: 
• attendance at conferences/workshops/
trainings as participants,
• attendance at conferences/workshops/
trainings as presenters,
• meetings with other EC institutions,
• bilateral meetings with selected external 
organisations or individual experts,
• attendance at events related to the CAN-
CON (European Guide on Quality Im-
provement in Comprehensive Cancer 
Control) joint action,
• ECIBC updates, and
• meetings analysis.
3. Methods
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During 2015, the JRC organised nine bilateral 
meetings with representatives of various or-
ganisations, associations, networks or EU pro-
jects. JRC staff (mainly HQ team members) 
attended 16 external meetings (e.g. seminars, 
conferences, trainings, workshops, working 
groups) and participated in three meetings 
within the CANCON joint action framework.
In September 2015, the JRC organised the kick 
off meetings of the Guidelines Development 
Group (GDG) and the Quality Assurance 
Scheme Development Group (QASDG). 
The GDG will support the European Com-
mission in developing the European guidelines 
for breast cancer screening and diagnosis. The 
QASDG will support the European Com-
mission in developing the European Qual-
ity Assurance Scheme for breast cancer services. 
The members of both groups were selected 
via a call for expression of interest issued by 
DG SANTE in 2014 and nominated on 7 
July 2015. The first meeting of the GDG was 
dedicated to the introduction to the ECIBC 
project, to the working modalities and to the 
scope of the guidelines. A short training on 
methods in guidelines development was also 
provided. The first meeting of the QASDG 
was dedicated to the introduction to the EC-
IBC project, to the working modalities and 
to the scope of the scheme. The full descrip-
tion of both events can be found in the Euro-
pean Commission Initiative on Breast Cancer: 
kick-off meetings’ report (in preparation).
Also, the JRC together with the European 
Association of Research and Technology 
Organisations (EARTO), the European 
Com mittee for Standardization (CEN), the 
European Committee for Electrotechnical 
Standardization (CENELEC), and the Dir-
ectorate-General for Internal Market, Indus-
try, Entrepreneurship and SMEs organised 
the conference entitled ‘Putting Science 
into Standards: Evidence-based quality as-
surance–an example for breast cancer’. The 
scope of this conference was to bring the 
scientific and standardisation communities 
closer together with a prime focus on the 
European Commission Initiative on Breast 
Cancer (ECIBC). Understanding the pro-
cesses involved in the ECIBC project, in 
particular ‘healthcare’ accreditation, and 
seeing whether standardisation may play a 
role in supporting the development and im-
plementation of the European QA scheme, 
was one of the main objectives of this con-
ference. This event is described in the PSIS 
report (in preparation). 
4.1. List of stakeholders 
Table 1 provides the list of European and in-
ternational organisations/associations, pro-
fessional societies and patients’ associations 
approached by the JRC since 2011. Stake-
holders listed in italics were first approached 
in 2015.
4. Results
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Table 1. Stakeholders (European and international organisations, professional societies, patients’ associations) ordered by acronym.
No Name Activity Website
1 ANEC ANEC is the European consumer voice in standardisation. 
They represent the European consumer interest in the crea-
tion of technical standards, especially those developed to 
support the implementation of European laws and public 
policies.
http://www.anec.eu/anec.asp
2 Austrian 
Standards 
Institute
The Austrian Standards Institute is a non-profit service 
organization founded in 1920, and its subsidiary Austrian 
Standards plus GmbH, was established in 2008. Austrian 
Standards supports the economy, administration, science 
and consumers in setting standards; organizes and manages 
committees drafting and developing standards,; publishes 
national, European and International standards.
https://www.austrian-stand-
ards.at/en/home/
3 BCN – Breast 
Centres Network
Breast Centres Network is the first international network of 
clinical centres exclusively dedicated to the diagnosis and 
treatment of breast cancer. It is a project of ESO (European 
School of Oncology) with the aim to promote and improve 
breast cancer care in Europe and throughout the world. 
The network includes Breast Units (Multidisciplinary Breast 
Centres) that fulfil minimum requirements to be considered 
referral centres.
http://www.breastcentresnet-
work.org/
4 CEN/CENELEC 
– European 
Committee for 
Standardization
CEN/CENELEC was officially created as an international 
non-profit association based in Brussels on 30 October 1975. 
Through its services it provides a platform for the develop-
ment of European Standards and other technical specifica-
tions. CEN is a major provider of European Standards and 
technical specifications. It is the only recognized European 
organization according to Directive 98/34/EC for the planning, 
drafting and adoption of European Standards in all areas of 
economic activity with the exception of electrotechnology 
(CENELEC) and telecommunication (ETSI). 
http://www.cen.eu/cen/pages/
default.aspx
5 CPME – Comité 
permanent des 
médecins 
Européens
The Standing Committee of European Doctors (CPME) repre-
sents national medical associations across Europe.
http://www.cpme.eu/
6 DGS - German 
Society of Seno-
logy (Deutsche 
Gesellshaft für 
Senologie)
DGS started an accreditation system as a pilot project from 
the University-Hospital in Tübingen in 2002. The system is 
now completely implemented all over Germany; more than 
93% of primary breast cancer patients are now diagnosed 
and treated in Certified Breast Cancer Centres.
http://www.senologie.org/
7 DKG – German 
Cancer Society 
(Die Deutsche 
Krebsgesells-
chaft)
The German Cancer Society (DKG) is the largest scientific and 
professional oncology society in Germany, based in Berlin. 
Overall, the DKG has approximately 6 600 members. The DKG is 
a public health institution that works in formal cooperation with 
politicians, professional societies, service and product provid-
ers in healthcare markets, and patient claims for the benefit of 
cancer patients. It represents the Federal Republic of Germany 
in international organisations such as the International Union 
Against Cancer (UICC) and the European Union. The DKG is 
linked with all European cancer societies and is actively commit-
ted to the advancement of a common European health policy.
http://www.krebsgesellschaft.
de/
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Table 1. (cont.)
No Name Activity Website
8 EA – European 
co-operation for 
Accreditation 
The European co-operation for Accreditation (EA) is an 
association of national accreditation bodies in Europe 
that are officially recognised by their national govern-
ments to assess and verify – against international stand-
ards – organisations that carry out evaluation services 
such as certification, verification, inspection, testing 
and calibration (also known as conformity assessment 
services).
http://www.european-accreditation.
org/
9 EAPC – European 
Association of 
Palliative Care
The EAPC strives to develop and promote palliative care 
in Europe through information, education and research 
using multi-professional collaboration, while engaging 
with stakeholders at all levels.
http://www.eapcnet.eu/
10 EAPM – European 
Alliance for 
Personalised 
Medicine
Founded in 2012, EAPM brings together Europe’s leading 
healthcare experts, healthcare organisations and institu-
tions, and patient advocates to improve patient care by 
accelerating the development, delivery and uptake of per-
sonalised healthcare including personalised medicine and 
diagnostics. EAPM works developing case studies, organis-
ing workshops, education, training and communication.
http://euapm.eu/
11 EARTO – Euro-
pean Association 
of research 
and technology 
organisations
EARTO is a non-profit association that represents the 
interests of Europe’s Research and Technology Organisa-
tions (RTO) community towards European institutions 
and offers its members opportunities for networking and 
professional improvement.
http://www.earto.eu/
12 ECCC – European 
Cancer Care 
Certification 
European Cancer Care is an association which has been 
appointed by Eusoma to develop the voluntary certifica-
tion process of breast centres.
http://www.cancercarecert.biosta-
tistica.net/index.php
13 ECCO – European 
CanCer Organi-
sation
ECCO is a not-for-profit federation that exists to uphold 
the right of all European cancer patients to the best pos-
sible treatment and care, promoting interaction between 
all organisations involved in cancer at European level.
http://www.ecco-org.eu/
14 ECL – Associa-
tion of European 
Cancer Leagues 
ECL is a pan-European umbrella organisation of national 
and regional cancer leagues. It provides advocacy for the 
Members of European Parliament (MEPs) Against Cancer 
(MACs) and is actively involved in Cancer Joint Actions, 
the health and nutrition platform, and the National Can-
cer Control Plans.
http://www.europeancancer-
leagues.org/
15 ECN – European 
Cancer Network
ECN has the scope to integrate new Member States and 
applicant countries into the mainstream of European 
efforts toward continuous improvement of best prac-
tices in secondary cancer prevention. Assistance was 
provided for the implementation of evidence-based 
screening tests for breast, cervical and colorectal cancer 
recommended in the Commission proposal for a Council 
recommendation on cancer screening which is linked to 
European Cooperation on Development and Implemen-
tation of Cancer Screening and Prevention Guidelines 
(ECCG).
http://ec.europa.eu/eahc/projects/
database.html?prjno=2004309
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Table 1. (cont.)
No Name Activity Website
16 ECP – European 
Cancer 
Prevention 
Organization
ECP was established in the early 1980s in order to foster 
action to prevent cancer.
http://ecpo.org/
17 ECPC – European 
Cancer Patient 
Coalition
Established in 2003, the European Cancer Patient Coali-
tion is the voice of the European cancer patient com-
munity, uniquely representing the interests of all cancer 
patient groups. It was set up: to represent the views of 
cancer patients in the European healthcare debate; to 
enable and empower cancer patients by educating them 
about cancer and advocacy skills and to provide a forum 
for European cancer patients to exchange information 
and share concerns on cancer care policies in their coun-
tries and best practice experiences. 
http://www.ecpc.org/ 
18 EFOMP – 
European 
Federation of 
Organisations in 
Medical Physics  
EFOMP is an umbrella organisation to all national 
member organisations (NMOs) having as their principal 
category of members medical physicists in Europe.
http://www.efomp.org/ 
19 EMA – Euro-
pean Medicines 
Agency 
EMA is a decentralised agency of the European Union. 
The Agency is responsible for the scientific evaluation of 
medicines developed by pharmaceutical companies for 
use in the European Union.  
http://www.ema.europa.eu 
20 EONS – Euro-
pean Oncology 
Nursing Society 
The European Oncology Nursing Society is a pan-Euro-
pean organisation dedicated to the support and develop-
ment of cancer nurses. 
http://www.cancernurse.eu/ 
21 EORTC – 
European 
Organisation for 
Research and 
Treatment of 
Cancer 
The aims of EORTC are to develop, conduct, coordinate, 
and stimulate translational and clinical research in 
Europe to improve the management of cancer and 
related problems by increasing survival but also patient 
quality of life. 
http://www.eortc.org/ 
22 ESMO – 
European Society 
for Medical 
Oncology 
The European Society for Medical Oncology (ESMO) is 
a non-profit professional medical oncology society in 
Europe. ESMO offers post-graduate education and train-
ing in clinical cancer care and research, and produces 
evidence-based recommendations for basic standards of 
cancer care.  
http://www.esmo.org/ 
23 ESO – European 
School of On-
cology 
ESO has the aim of contributing to the reduction of 
deaths from cancer due to late diagnosis and/or inad-
equate treatment, by improving the skills of all health 
professionals dealing with cancer patients. 
http://www.eso.net/ 
24 ESR – European 
Society of Radi-
ology
ESR is an apolitical, non-profit organisation, dedicated to 
promoting and coordinating the scientific, philanthropic, 
intellectual and professional activities of radiology in all 
European countries. 
http://www.myesr.org/start/
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Table 1. (cont.)
No Name Activity Website
25 EUPHA – 
European Public 
Health Associa-
tion
EUPHA is an umbrella organisation for public health 
associations and institutes in Europe. Founded in 1992, 
EUPHA is an international, multidisciplinary, scientific 
organisation, bringing together approximately 14 000 
public health experts for professional exchange and 
collaboration throughout Europe. Its mission is to build 
capacity and knowledge in the field of public health, 
and to support practice and policy decisions through 
scientific evidence and producing and sharing knowledge 
with its members and partners in Europe. EUPHA activity 
is based on four pillars: Research, Policy, Practice, and 
Training and Education. In addition, 20 theme-specific 
sections are active.
http://www.eupha.org/
26 EUREF – 
European Refer-
ence Organisa-
tion for Quality 
Assured Breast 
Screening and 
Diagnostic 
Services
EUREF is a pan-European organisation, widely drawn 
from different MSs and is operated on a non-profit making 
basis. 
EUREF commits itself to the development and dissemi-
nation of the European Guidelines, certification of breast 
services and mammography equipment, training and 
provides support and advice on such issues.
http://www.euref.org/
27 Europa Donna 
– The European 
Breast Cancer 
Coalition 
Europa Donna is an independent non-profit organisation 
whose members are affiliated groups from countries 
throughout Europe. It works to raise awareness of breast 
cancer and to mobilise the support of European women 
in pressing for improved breast cancer education, ap-
propriate screening, optimal treatment and increased 
funding for research. Europa Donna represents the 
interests of European women regarding breast cancer to 
local and national authorities as well as to institutions of 
the European Union.
http://www.europadonna.org/
28 Europa Uomo 
– The European 
Prostate Cancer 
Coalition
Europa Uomo is the European advocacy movement 
for the fight against prostate cancer. Europa Uomo’s 
objective is to increase awareness on prostate cancer in 
Europe. Europa Uomo is a European coalition of patients 
supporting groups for prostate diseases in general and 
prostate cancer in particular.
http://www.europa-uomo.org
29 EUROPREV 
– European 
Network for 
Prevention and 
Health Promo-
tion in Family 
Medicine and 
General Practice
EUROPREV aims to promote evidence-based disease 
prevention in general practice/family medicine in Europe.
http://www.europrev.org/
30 EUSOBI – 
European 
Society of 
Breast Imaging
European Society of Breast Imaging (EUSOBI) is a 
society focused on breast imaging and creating unique 
medical and scientific standards in the field, it provides 
various training and fellowship programmes on breast 
imaging.
http://www.eusobi.org/
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Table 1. (cont.)
No Name Activity Website
31 EUSOMA –
European 
Society of 
Breast Cancer 
Specialists
EUSOMA is a multidisciplinary society committed to 
improving and harmonizing the standards of breast 
cancer care in Europe to make sure that all women have 
access to the best possible specialist breast diagnosis 
and treatment services.
http://www.eusoma.org/
32 Fundación para 
el Fomento de 
la Investigación 
Sanitaria y 
Biomédica de 
la Comunidad 
Valenciana 
(FISABIO-CSISP)
FISABIO (the Foundation for the Promotion of Health and 
Biomedical Research of the Valencian Community) is a 
non-profit scientific and social institution, whose primary 
purpose is to encourage, promote and develop scientific, 
technical, health and biomedical research in the Valencian 
Community (Spain).
http://www.csisp.gva.es/
33 G-I-N – 
Guidelines 
International 
Network 
G-I-N is a global network that supports evidence-based 
health care and improved health outcomes by reducing 
inappropriate variation throughout the world. G-I-N mis-
sion is to lead, strengthen and support collaboration and 
work within the guideline development, adaptation and 
implementation community.
http://www.g-i-n.net/
34 GISMa – Gruppo 
Italiano Screen-
ing Mammo-
grafico
GISMA is the Italian multidisciplinary association that 
promotes the diffusion of population-based breast 
cancer screening programmes in Italy and monitors 
the quality of diagnosis and treatment offered in these 
programmes.
http://www.gisma.it/
35 IACR – Interna-
tional Associa-
tion of Cancer 
Registries
IACR is a professional society dedicated to fostering the 
aims and activities of cancer registries worldwide. It is 
primarily for population-based registries, which collect 
information on the occurrence and outcome of cancer in 
defined population groups.
http://www.iacr.com.fr/
36 IARC - Interna-
tional Agency 
for Research on 
Cancer
IARC is the specialised cancer agency of the World 
Health Organization.
The objective of the IARC is to promote international col-
laboration in cancer research.
http://www.iarc.fr/
37 CCIb – Centro 
Cochrane Iber-
oamericano
The Iberoamerican Cochrane Centre was formally regis-
tered in 1997 as the Spanish Cochrane Centre and is one 
of the fourteen international centres of Cochrane. 
http://es.cochrane.org/es
38 ICC – Italian 
Cochrane Centre
ICC is affiliated with the Cochrane Collaboration (CC). The 
objectives of the ICC are centred on supporting various 
activities of the Cochrane Collaboration within Italy.
http://www.cochrane.it/
39 IPOS – Interna-
tional Psycho-
Oncology 
Society
The International Psycho-Oncology Society (IPOS) was 
created to foster international multidisciplinary commu-
nication about clinical, educational and research issues 
that relate to psycho-oncology and primary psychosocial 
dimensions of cancer.
http://www.ipos-society.org/
40 JCI – Joint 
Commission 
International
JCI works with health care organizations, governments, 
and international advocates to promote rigorous stand-
ards of care in three ways: accreditation, education, and 
advisory services.
http://www.jointcommissioninter-
national.org/
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Table 2 provides the list of projects and net-
works contacted by the JRC since 2011. 
Stakeholders listed in italics were first ap-
proached in 2015.  
Table 1. (cont.)
No Name Activity Website
41 NICE – National 
Institute for 
Health and Care 
Excellence
NICE provides national guidance and advice to improve 
health and social care. It was originally set up in 1999 
as the National Institute for Clinical Excellence, a special 
health authority, to reduce variation in the availability 
and quality of NHS treatments and care. In 2005, it 
began developing public health guidance to help prevent 
ill health and promote healthier lifestyles. In  2013 it 
took responsibility for developing guidance and quality 
standards in social care.
https://www.nice.org.uk/
42 OECI – 
Organisation of 
European Can-
cer Institutes
The primary objectives of OECI's 68 associated European 
Cancer Centres are to improve communication and to 
increase collaborative activities among European cancer 
institutes. These goals are achieved by promoting and 
strengthening Comprehensive Cancer Centres in Europe.
http://www.oeci.eu/
43 Senonetwork 
– Associazione 
Senonetwork 
Italia Onlus
Senonetwork is the Italian network of breast cancer 
services. It has the goal of promoting the treatment of 
breast cancer diseases in Italy in devoted centres which 
respect the European standards.
http://www.senonetwork.it/
44 SIS – Senologic 
International 
Society
SIS is composed of non-profit associations, societies, 
scientific institutions, and groups, aiming to the promo-
tion of knowledge in biology and medicine in human 
sciences, related to the breast, in order to establish an 
international federation, with the intention of advancing 
prevention, diagnosis and treatment of breast diseases, 
to spread senologic knowledge and to promote interac-
tion with the community. 
http://www.sisbreast.org/
Table 2. Stakeholders (projects and networks).
No Name Activity Website
1 BenchCan The general objective of BENCH-CAN is to benchmark 
comprehensive cancer care & yield best practice exam-
ples in a way that contributes to improving the quality of 
interdisciplinary patient treatment.
Co-funded by the Health Pro-
gramme of the European Union
2 CANCON – 
European Guide 
on Quality 
Improvement in 
Comprehensive 
Cancer Control
Purpose of this Joint Action is to address comprehensive 
cancer care across the member states and to set the 
guiding principles for its achievement.
European Commission – Joint 
Action
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Table 2. (cont.)
No Name Activity Website
3 COMET – Core 
Outcome 
Measures in 
Effectiveness 
Trials
The COMET Initiative brings together people interested in 
the development and application of agreed standardised 
sets of outcomes, known as ‘core outcome sets’. These 
sets represent the minimum that should be measured 
and reported in all clinical trials of a specific condi-
tion, and are also suitable for use in a clinical audit or 
research other than randomised trials. 
MRC Hub for Trials Methodology 
Research (HTMR) Network
European Commission under the 
Seventh Framework Programme.
NHS National Institute for Health 
Research (NIHR)
4 DECIDE – 
Developing and 
Evaluating
Communication 
strategies to 
support Informed 
Decisions and 
practice based 
on Evidence
DECIDE is a 5-year project (running from January 2011 
to 2015) whose objective is to improve the dissemination 
of evidence-based recommendations by building on the 
work of the GRADE Working Group to develop and evalu-
ate methods that address the targeted dissemination of 
guidelines.
European Commission under the 
Seventh Framework Programme
5 ECCG – European 
Cooperation on 
Development 
and Implemen-
tation of Cancer 
Screening and 
Prevention 
Guidelines
The project aims to develop supplements to the cur-
rent EU guidelines on specific topics, to maintain an EU 
forum for cooperation in cancer screening and guideline 
development and to describe the current epidemiology 
of breast and cervical cancer in the EU. 
European Commission
6 ECHO – Euro-
pean Collabora-
tion for Health 
Optimization
The ECHO project is an international effort to bring 
together the hospital databases of several European 
countries and make the data available via an online 
summary tool.
European Commission under the 
Seventh Framework Programme
7 ENCR – Euro-
pean Network 
of Cancer 
Registries
The ENCR promotes collaboration between cancer regis-
tries, defines data collection standards, provides training 
for cancer registry personnel and regularly disseminates 
information on incidence of and mortality from cancer in 
the European Union and Europe.
European Commission
8 EPAAC – Europe-
an Partnership 
for Action 
Against Cancer 
Joint Action
EPAAC was a partnership that put together the efforts 
of different stakeholders into a joint response to prevent 
and control cancer. The partnership is taken forward 
through a new Joint Action – CANCON.
European Commission – Joint 
Action
9 EUnetHTA EUnetHTA is a network of government appointed organi-
sations (from EU Member States, EU-accession coun-
tries, plus EEA and EFTA countries) and a large number 
of relevant regional agencies and not-for-profit organi-
sations that produce or contribute to health technology 
assessment HTA in Europe
European Commission – Joint 
Action
10 EURECCA – 
European 
Registration of 
Cancer Care 
The EURECCA project aims to improve the quality of can-
cer care through audits (of data). The project is ongoing 
for colorectal cancer and at the initial stage for breast 
cancer.
European Society of Surgical On-
cology (ESSO); European CanCer 
Organisation (ECCO)
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The individual stakeholders usually have 
one or more professional affiliations. A non-
exhaustive list of public and private institu-
tions contacted/met by the JRC (through 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
one or more of their representatives or em-
ployees) is reported in Table 3. Institutions 
listed in italics were first approached in 2015.
Table 2. (cont.)
No Name Activity Website
11 EUREGHA 
– European 
Regional and 
Local Health 
Authorities
EUREGHA is a network of 13 European Regional and 
Local Health Authorities focused on public health, which 
aim is to promote collaboration amongst regions and 
local authorities, more specifically regional and local 
health authorities in Europe, within the framework of the 
policies relating to public health and healthcare, as well 
as to establish focused collaboration with the institu-
tions of the European Union and with the international 
and public organisations related to public health and 
healthcare throughout the world.
European Regions: Lower Austria 
(AT); Catalunya (ES); East of 
England (UK); Flanders (BE); 
Skåne (SE); Västra Gotäland 
(SE); Veneto (IT); North West of 
England (UK); Podlaskie (PL)
12 EUROCAN – 
EurocanPlatform
EUROCAN brings together 28 European cancer Institu-
tions and organisations to work together in a unique 
collaboration. The centres share infrastructures and 
collaborate on projects to help advance cancer research 
and treatment.
The aim of the project is to improve outcomes for cancer 
patients and reduce mortality. This is being achieved 
by focusing on three key areas of research: prevention, 
early detection and improved treatments.
European Commission
13 EUROCARE 
– Survival of 
cancer patients 
in Europe
EUROCARE is the largest collaborative research project 
on cancer survival in Europe. The project started in 1989 
under the initiative of two research institutes, Istituto 
Nazionale Tumori (Milan, Italy) and Istituto Superiore 
di Sanità (Rome, Italy), with the participation of a large 
number of population-based Cancer Registries through-
out Europe. The aims of the study are: to provide an 
updated description of cancer survival time trends and 
differences across European countries, to measure can-
cer prevalence, and to study patterns of care of cancer 
patients.
Italian Ministry of Health, Com-
pagnia di San Paolo, CARIPLO 
Foundation
14 PaSQ – Patient 
Safety and 
Quality of Care  
Working Group
The Commission Patient Safety and Quality of Care 
Working Group brings together representatives from all 
27 EU countries, EFTA countries, international organisa-
tions and EU bodies. The Group assists in developing the 
EU patient safety and quality agenda
http://ec.europa.eu/health/pa-
tient_safety/policy/index_en.htm
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Table 3. Public and private institutions indirectly contacted through one or more of their representatives
No Name Country
1. Abbott Diagnostics Italy
2. Accredia Italy
3. Ambulatorio di omeopatia, Centro di riferimento regionale toscano, Ospedale Campo di 
Marte, Azienda USL 2 Lucca
Italy
4. Anticancer Fund Belgium
5. Azienda Sanitaria Locale (ASL) di Milano Italy
6. Breast Centre - Humanitas Cancer Centre (BCH) Italy
7. Champalimaud Foundation Portugal
8. CERMET Italy
9. Centre fribourgeois de dépistage du cancer du sein Switzerland
10. The Christie NHS Foundation Trust United Kingdom
11. Cologne University Germany
12. Croatian National Institute of Public Health Croatia
13. Danish Health and Medicines Authority - Hospital Services and Emergency Management Denmark
14. Deutsche Akkreditierungsstelle GmbH (DAkkS) Germany
15. Direção-Geral da Saúde Portugal
16. Emilia-Romagna Local Health Unit Italy
17. Faculty of Health Sciences – University of Copenhagen Denmark
18. Swiss cancer screening, Fédération suisse des programmes de dépistage du cancer Switzerland
19. Fakultní nemocnice Olomouc Czech Republic
20. Gesundheit Österreich GmbH Austria
21. Gynaecological department (women’s clinic) Bürgerspital Switzerland
22. Haute Autorité de Santé France
23. Institut Català d’Oncologia Spain
24. Institut National du Cancer France
25. Institute for Health Research - Lancaster University United Kingdom
26. Institute of Oncology Ljubljana Slovenia
27. Institute for Oncology Veneto Italy
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Table 3. (cont.)
No Name Country
28. Institute of Public Health Brussels Belgium
29. Institute of Public Health of the Republic of Slovenia Slovenia
30. Karolinska University Hospital Sweden
31. Kleijnen Systematic Reviews Ltd (KSR) United Kingdom
32. Kooperationsgemeinschaft Mammographie GbR Germany
33. Lazio Regional Health Authority Italy
34. London Breast Institute United Kingdom
35. Mammografi Sverige - Unilabs AB Sweden
36. Mario Negri Institute Italy
37. Mass Screening Registry Finland Finland
38. Medical University of Vienna Austria
39. Ministero de Sanidad y Politica Social Spain
40. Ministry for Health, the Elderly and Community Care Malta
41. Ministry of Health Cyprus
42. Ministry of Health Italy
43. Ministry of Health Poland
44. Ministry of Health of the Republic of Lithuania Lithuania
45. Ministry of Health, Welfare and Sport The Netherlands
46. Ministry of Social Affairs Estonia
47. Ministère des affaires sociales et de la santé France
48. National Cancer Control Programme Ireland
49. National Cancer Institute Milano (Istituto Nazionale Tumori – INT) Italy
50. National Health Service (NHS) United Kingdom
51. Norwegian Directorate of Health Norway
52. The Netherlands Cancer Institute The Netherlands
53. Onkologický ústav sv. Alžbety, s.r.o. Slovakia
54. Oslo University Hospital Norway
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Table 3. (cont.)
No Name Country
55. Piedmont Reference Centre for Epidemiology and Cancer Prevention (CPO Piemonte) Italy
56. Polytechnic University of Milan Italy
57. Public Association for Healthy People Hungary
58. Radboud University Medical Centre Nijmegen The Netherlands
59. Riga East University Hospital Latvia
60. The Royal Marsden, Downs Road United Kingdom
61. Scientific Institute of Public Health Belgium
62. SP Technical Institute of Sweden Sweden
63. Specialized Hospital for Active Treatment in Oncology Bulgaria
64. Syöpäjärjestöt – Cancer Society of Finland Finland
65. Swiss Accreditation Service (SAS) Switzerland
66. Tuscan Network for Integrative Medicine Italy
67. Tübingen University Germany
68. United Kingdom Accreditation Service (UKAS) United Kingdom
69. Università di Modena e Reggio Emilia Italy
70. University College Hospital, London United Kingdom
71. University of Groningen Netherlands
72. University of Surrey United Kingdom
73. University of Warwick United Kingdom
74. Vivantes Center for Breast Diseases Germany
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4.2. Description of events  
4.2.1. Attendance at conferences/
workshops/trainings as participants
Table 4. Attendance at conferences/workshops/trainings as participants.
No Date Event Organiser Title Place Impact
1. 20 /01 /2015 Meeting JRC Participate to 
the meeting 
with CEN/
CENELEC 
and EARTO 
on the 2015 
joint meet-
ing ‘Putting 
Science into 
standards’
Brussels (BE) The meeting was the follow-up of the 
previous meeting held in December 2015 
where the choice of the topic for 2015 joint 
meeting (co-organised annually by JRC 
plus CEN/CENELEC plus EARTO) was dis-
cussed. JRC proposal on standardisation 
in the Healthcare area using the Breast 
Cancer Accreditation scheme as a model 
was taken very positively by EARTO, leav-
ing some scepticism in CEN/CENELEC.
This second meeting succeeded in 
convincing them that the event can offer 
a platform for open discussion among 
the main stakeholders (from industry to 
research, from health technology assess-
ment to patients, from healthcare Institu-
tions to insurances) to receive a feed-back 
on standardisation needs and formats in 
this area.
2. 29-30/ 04/2015 Workshop Association 
of European 
Cancer 
Leagues (ECL)
ECL PSWG 
(Patient 
Support Work-
ing Group) 
meeting
Limassol (CY) The meeting focused on different ap-
proaches in the Member States towards 
the CAM (Complementary alternative 
Medicine) used in cancer patients. The 
most developed in the integration of the 
CAM seems to be Toscana Region, where 
CAM therapies are included in the regional 
health legislation.
3. 07-9/05/2015 Conference European 
Society for 
Medical On-
cology
IMPAKT 
Breast Cancer 
Conference
Brussels (BE) The main topic of the conference was 
improving care and knowledge through 
translational research in breast cancer. 
There were approximately 500 registra-
tions to this conference which apparently 
is the only one in the field of translational 
research in breast cancer. The programme 
focused on the clinical significance of 
genomic patterns and mutations, the mu-
tational evolution in breast cancer, cellular 
origin of breast cancer and translational 
research in the context of clinical trials in 
early breast cancer. The need to standard-
ise PET images was brought up as well as 
the need for cross talk between radiolo-
gists and molecular oncologists in order to 
show the clinical usefulness of imaging.
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Table 4. (cont.)
No Date Event Organiser Title Place Impact
4. 7-8/05/2015 Workshop German 
Cancer 
Society, in 
cooperation 
with UICC
2st European 
Round Table 
Meeting to 
Discuss Qual-
ity of Cancer 
Care
Berlin (DE) Several issues that may impact the 
European QA Scheme were discussed, 
such as continuity and coordination of 
care, patient’s involvement and use of 
data and cancer registries. The conclusions of 
the workshop are published in Ortman O, 
Torode J and Helbig U. Improving structural 
development in oncology: transformation 
of theoretical health care standards and 
knowledge into a practical approach. 
J Cancer Res Clin Oncol 2015; DOI 10.1007/
s00432-015-2052-9 
5. 22-24/06/2015 Conference Organisation 
of European 
Cancer Insti-
tutes (OECI)
OECI 2015 
Oncology 
Days
Porto (PT) The qualitative and quantitative tools de-
veloped within the BenchCan project and 
the experience within the benchmarking 
process during the pilot sites visits were 
presented. The feedback regarding the 
patients’ needs was also highlighted by a 
representative of ECPC.
OECI core activities were also covered. 
The process of OECI for accreditation and 
designation was discussed. The practical 
issues raised by the pilot centres for the 
BenchCan project might be useful also for 
the QA scheme (e.g. creation of a glossary 
of terms – different countries interpreted 
in different ways some indicators).
6. 3-4/09/2015 – Workshop CERES – 
Cologne 
center for 
ethics, rights, 
economics, 
and social 
sciences of 
health
IMPAKT 
Breast Cancer 
Conference
Brussels (BE) The role, the scope and the goals of the 
RiskAP project were discussed. The main 
aim will be to define the existence and 
needs of evidence for genetic testing, also 
in the context of stratified breast cancer 
screening, and preventive treatment. 
The working group will meet other four 
times for preparing a position paper. The 
last meeting will be hosted by the German 
Federal Ministry of Health.
One of the draft Work packages proposed 
would include management of data 
and the members of the working group 
proposed to have a dialogue with cancer 
registries.
7. 21/09/2015 Workshop Institute for 
Prospective 
Technologi-
cal Studies 
(IPTS)-JRC 
Sevilla
Presentation 
of the MAFEIP 
tool
Brussels (BE) The Healthcare Quality Team may con-
sider using the MAFEIP tool to evaluate 
the impact of the European Commission 
Initiative on Breast Cancer.
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4.2.2. Attendance at conferences/
workshops/trainings as presenters
Table 5 presents the list of events held in 2015 
where the JRC gave presentations related to 
the ECIBC.
Table 4. (cont.)
No Date Event Organiser Title Place Impact
8. 25-29/09/2015 Congress European 
Society for 
Medical 
Oncology 
(ESMO)
European 
Cancer 
Congress 2015 
(ECC 2015)
Vienna (AT) The ECC 2015 combined the efforts of the 
most important European oncology pro-
fessionals with the aim of improving the 
prevention, diagnosis, treatment and care 
of cancer patients. 
Particularly sessions focusing on the mul-
tidisciplinary approach in cancer treatment 
and care, and implementation of clinical 
practice guidelines will have impact on 
the ECIBC future work on QA scheme and 
guidelines.  
Discussions to be continued on the inclu-
sion of the rare breast cancer in the Euro-
pean Reference Network on rare cancers. 
The presence of ECIBC in the future breast 
and general oncology conferences is im-
portant both for the visibility of the project 
and for enhancing collaboration with  
different organizations and stakeholders.
No Date Event Organiser Title Impact
1. 25-29/09/2015 Congress European 
Society for Medical 
Oncology (ESMO)
European 
Cancer 
Congress 2015 
(ECC 2015)
EU voluntary accreditation scheme for 
breast cancer services and revision/inte-
gration of the 4th edition of the European 
guidelines
2. 1-4/06/2015 International 
Cancer Screening 
Network
International Cancer 
Screening Network 
(ICSN) triennial 
conference
Rotterdam (NL) Presence and characteristics of breast can-
cer screening programmes in 28 European 
countries: results from two international 
surveys
3. 19/06/2015 Senonetwork
Eusoma
Conferenza Stato – 
Regioni for Breast 
Units Italian Regula-
tion implementation
‘Breast Unit: il 2016 
è alle porte. 5th 
Pavia Update on 
Breast Cancer’
Milano (IT) The European Commission Initiative on 
Breast Cancer: a voluntary quality assurance 
scheme for Breast Cancer Services
Table 5. Attendance at conferences/workshops/trainings as presenters.
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4.2.3. Meetings with EC institutions
During 2015, the HQ team participated in the 
EU Patient Safety and Quality of Care Expert 
Group (the former Patient Safety and Quality 
of Care Working Group) meetings coordinated 
by DG SANTE on a regular basis and in the 
Accreditation Steering Group organised by the 
Directorate-General for Internal Market, 
Industry, Entrepreneurship and SMEs. The 
JRC also had meetings with DG SANTE, 
DG GROW, DG RTD and EMA. These 
events are not described as they do not fall 
under the scope of this report. Also JRC 
attended the meetings of the Commission 
Expert Group on Cancer Control.
4.2.4. Attendance at events related to
the CANCON joint action
In 2015, the JRC participated in several 
events organised within the framework of 
the CANCON joint action. A presentation 
entitled Potential areas of collaboration of the 
Joint Research Centre with CANCON WP9 
was given at the CANCON WP9 (Cancer 
Screening) kick-off meeting.
Table 5. (cont.)
No Date Event Organiser Title Impact
4. 2-3/10/2015 EUSOBI EUSOBI Annual 
Scientific Meeting 
2015
London (UK) The New European Guidelines for breast 
cancer screening and diagnosis
5. 08-09/10/2015 DG Health and 
Food Safety
2nd conference on 
European Refer-
ence Networks
Lisbon (PT) JRC registries project and potential interac-
tion with ERNs
6. 15-17 October 
2015
European Public 
Health Association
8th European Public 
Health Conference
Milan (IT) Implementation and equity trends in twenty-
five years of European mammography 
screening programmes.
Requirements for breast cancer data collec-
tion: systematic review of European funded 
projects
7. 12-13/11/ 2015 Ministry of Educa-
tion, Science and 
Sport, Republic of 
Slovenia
Joint Research 
Centre & Slovenia
Thematic event to 
foster cooperation
Ljubljana (SI) The European Commission Initiative on 
Breast Cancer
8. 20/11/ 2015
Lecture 
The Hellenic School 
of Senology
Greece ECIBC 
National Contact – 
GDG member
Lecture on JRC 
work on Breast 
Cancer
Athens (GR) The European Commission Initiative on 
Breast Cancer
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Table 6. JRC participation at CANCON events.
No Period Meeting Location
1. 12-13/02/2015 Participation of the JRC at the CanCon WP9 (Screening) 
Coordination meeting
Lyon (FR)
2. 12-13/05/2015 Participation of the JRC at the CANCON Stakeholder 
Forum, CANCON WP2 meeting and CANCON WP5 Cancer  
Survivorship and Policy Dialog with EP MAC
Brussels (BE)
3. 17-18/09/2015 Participation of the JRC at the CanCon WP9 (Screening) 
Breast Cancer meeting with the presentation 'Current 
status of breast cancer screening implementation in 
Europe'
Zagreb (HR)
4.2.5. Bilateral meetings
with organisations or individual experts
In 2015, nine bilateral meetings including 
videoconferences, teleconferences and on-
site meetings were organised with some of 
the stakeholders included in Tables 1 to 3.
4.3. ECIBC updates
 
Like in the previous years, ECIBC pre-
paratory activities included stakeholders 
meetings, participation in external events, 
literature searches, outsourcing services for 
ECIBC tasks (literature review), and publi-
cation of the reports:
Review and analysis of external quality assess-
ment of breast cancer services in Europe–Sup-
porting information from the development of a 
European Quality Assurance scheme for Breast 
Cancer Services.
Report of a survey on accreditation and con-
formity assessment in the field of breast cancer in
Europe–Supporting information from the na-
tional accreditation bodies for the European 
Commission initiative on breast cancer.
As mentioned in the results section, both 
the Guidelines Development Group and 
Quality Assurance Scheme Development 
Group (QASDG) were nominated in July 
2015 and the kick-off meetings were held in 
September.
Another important event was the conference 
entitled ‘Putting Science into Standards: 
Evidence-based quality assurance–an ex-
ample for breast cancer’ organised by JRC 
together with the European Association of 
Research and Technology Organisations 
(EARTO), the European Committee for 
Standardization (CEN), the European Com-
mittee for Electrotechnical Standardization 
(CENELEC), and the Directorate-General 
for Internal Market, Industry, Entrepreneur-
ship and SMEs.
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During 2015 the feasibility study and the 
deployment for the ECIBC web hub were 
performed.
The organisation of the Plenary of the 
ECIBC ‘Improving breast cancer screening, 
diagnosis and care in Europe and the launch 
of the ECIBC web hub will contribute also 
to the dissemination of the ECIBC.
4.4. Meetings analysis
The networking activities since the begin-
ning of the ECIBC are analysed. The meth-
ods used to perform the analysis have al-
ready been described in the report European 
Commission Initiative on Breast Cancer– 
ECIBC: organisation of project guiding and sup-
port meetings–Meetings 2014. ECIBC-defined 
keywords were assigned for each meeting. 
The keywords were grouped into clusters. A 
diagram showing the results can be seen in 
Figure 1. In the diagram, the numbers reflect 
the frequency of the keywords allocated to 
the meetings and not the total number of 
meetings. Based on these numbers, deci-
sions concerning networking and collabora-
tion priorities can be made.
Figure 1. Synthetic overview on area of interest for the ECIBC.
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2015 was an intensive year for ECIBC. The 
project gained visibility. The networking 
activities included participation in external 
events and meetings with stakeholders from 
the area of breast cancer, healthcare, quality 
assurance, methodological research, clinical 
trials, cancer research, complementary and 
alternative medicine, screening.
JRC will continue to present updates re-
garding ECIBC during future meetings and 
to meet stakeholders.
Conclusions
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Figure 1. Synthetic overview on area of interest for the ECIBC.
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